Nurse Sues After Being Terminated for Reporting Suspected Child Abuse
One can see how a situation like this could occur where parents refuse to communicate with each other.
Pediatrics
Xofluza Approved to Treat, Prevent Influenza in Pediatric Patients
The expanded approval was based on data from two phase 3 studies, miniSTONE-2 and BLOCKSTONE.
MPR Weekly Dose Podcast #126
Emergency use authorization for intradermal administration of Jynneos; treatment approved for endometriosis pain; Amazon among the companies to receive a FDA Warning Letter for selling unapproved drugs; a diabetes drug is found to contain a possible carcinogen; and a new scale that measures peripheral impedance and pulse rate.
Guideline Updated for Managing Hyperbilirubinemia in Newborns
All families should receive written and verbal education about neonatal jaundice before discharge
Most Parents Not Eager to Vaccinate Young Children Against COVID-19
Concerns about vaccine safety and effectiveness pose barriers to immunization
Stelara Approved for Pediatric Psoriatic Arthritis
The approval is supported by evidence from adequate and well-controlled studies of Stelara.
Ztalmy Oral Suspension Now Available for CDKL5 Deficiency Disorder
The approval was based on data from the phase 3 Marigold study that included patients aged 2 to 19 years with genetically confirmed CDKL5 gene mutation.
Preset Opioid Rx May Not Impact Pain Control After Tonsillectomy
Default number of doses in opioid prescriptions lowered for teens and young adults undergoing tonsillectomy
Benlysta Approval Expanded to Include Pediatric Lupus Nephritis
The Food and Drug Administration (FDA) has expanded the approval of Benlysta (belimumab) to include pediatric patients 5 to 17 years of age with active lupus nephritis who are receiving standard therapy. Benlysta, a B-lymphocyte stimulator (BLyS)-specific inhibitor, is also indicated for the treatment of patients 5 years of age and older with active systemic…
Less Than Half of Parents Plan to Get COVID-19 Vaccine for Youngest Children
About 43 percent of U.S. parents of children aged 6 months to 4 years said they would not get their children a COVID-19 shot
